09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Related
Seyfarth Synopsis: Since the enactment of New York City’s original Earned Sick Time Act (“ESTA”) ...
Read More >
For the first time in a number of years, overtime regulations under the Fair Labor Standards Act (FL...
Read More >
Addressing an issue of whether a letter exchange qualifies as a work for hire agreement under US cop...
Read More >
Today, the Supreme Court of the United States granted certiorari in the following cases: Our Lady o...
Read More >
Section 220 of the Delaware General Corporation Law affords stockholders a qualified right to inspec...
Read More >
Non-compete clauses are commonly included in M&A agreements. Although generally recognized as lawful...
Read More >